CNSPCNS Pharmaceuticals, Inc.

Nasdaq cnspharma.com


$ 0.21 $ 0.01 (2.59 %)    

Friday, 03-May-2024 15:26:43 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 0.2211
$ 0.21
$ 0.00 x 0
$ 0.00 x 0
$ 0.21 - $ 0.21
$ 0.19 - $ 2.98
84,084
na
832,966
$ 2.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-03-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 02-12-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-12-2020 12-31-2019 10-K
18 12-20-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cns-pharmaceuticals-q4-eps-095-up-from-382-yoy

CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.95) per share. This is a 75.13 percent increase over losses ...

 top-5-health-care-stocks-that-are-preparing-to-pump-in-february

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 why-ups-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-e...

 why-super-micro-computer-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket

Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) shares rose sharply in today’s pre-market trading as the company posted u...

 cns-pharmaceuticals-prices-4m-public-offering-of-13333334-common-shares-at-030share

The Company further agreed to issue to the investors Series A Warrants to purchase up to 13,333,334 shares of common stock and ...

 cns-pharmaceuticals-announces-successful-interim-analysis-of-efficacy-and-safety-data-in-potentially-pivotal-study-of-berubicin-independent-dsmb-recommends-continuing-clinical-trial-of-berubicin-without-modification

Independent DSMB recommends continuing clinical trial of Berubicin without modificationEnrollment expected to be complete in ea...

 cns-pharmaceuticals-presents-updated-safety-data-from-ongoing-study-evaluating-berubicin-in-advance-of-the-pre-planned-interim-analysis-of-efficacy

Data presented at the Society of NeuroOncology (SNO) 28th Annual MeetingBerubicin currently being evaluated in an ongoing poten...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION